Game Changers in Structural Heart Care: TAVR and MitraClip

Author(s): Laura Dechant

Contact Hours 1.00

CERP A 1.00

Expires Dec 31, 2025

Topics: Cardiovascular, Family-Centered Care

Population: Adult

Role: APRN

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

The number of patients who qualify for percutaneous treatment of valvular heart disease grows along with the proportion of Americans who are Baby Boomers.. APRNs must understand and implement current guidelines in the care of this population. Review of current guidelines, CMS regulations and postprocedure care are discussed. Case studies are presented to tie concepts together.

Objectives

  • Discuss American College of Cardiology (ACC) guidelines related to patient who require percutaneous TAVR or placement of MitraClip.
  • Identify necessary National Coverage Determination Criteria prior to scheduling procedures.
  • Review postprocedure management of TAVR and MitraClip.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.